Enzyme replacement therapy in type 1 and type 3 Gaucher's disease.
作者信息
Zimran A, Elstein D, Abrahamov A
出版信息
Lancet. 1995 Feb 18;345(8947):451-2. doi: 10.1016/s0140-6736(95)90432-8.
PMID:7853968
Abstract
摘要
相似文献
1
Enzyme replacement therapy in type 1 and type 3 Gaucher's disease.
Lancet. 1995 Feb 18;345(8947):451-2. doi: 10.1016/s0140-6736(95)90432-8.
2
[Enzyme therapy of Gaucher's disease].
Dtsch Med Wochenschr. 1993 Jun 25;118(25):964-5.
3
Treatment of Gaucher's disease.
N Engl J Med. 1993 May 27;328(21):1564-5; author reply 1567-8.
4
Low-dose versus high-frequency regimens in Gaucher's disease.
Lancet. 1996 Feb 10;347(8998):406-7. doi: 10.1016/s0140-6736(96)90591-7.
5
Low-dose versus high-frequency regimens in Gaucher's disease.
Lancet. 1995 Nov 25;346(8987):1434. doi: 10.1016/s0140-6736(95)92453-1.
6
Neurological features in Gaucher's disease during enzyme replacement therapy.
Acta Paediatr. 2001 Feb;90(2):229-31. doi: 10.1080/080352501300049587.
7
Treatment regimens in Gaucher's disease.
Lancet. 1995 Aug 26;346(8974):581-2. doi: 10.1016/s0140-6736(95)91422-6.
8
Enzyme-replacement therapy for Gaucher's disease.
N Engl J Med. 1991 Dec 19;325(25):1809-11. doi: 10.1056/NEJM199112193252513.
9
Replacement therapy with imiglucerase for type 1 Gaucher's disease.
Lancet. 1995 Jun 10;345(8963):1479-80. doi: 10.1016/s0140-6736(95)91038-7.
10
Imiglucerase and its use for the treatment of Gaucher's disease.
Expert Opin Pharmacother. 2008 Aug;9(11):1987-2000. doi: 10.1517/14656566.9.11.1987.
引用本文的文献
1
Hematopoietic stem cell transplantation for Gaucher disease.
Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD006974. doi: 10.1002/14651858.CD006974.pub4.
2
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy.
Core Evid. 2016 Oct 14;11:37-47. doi: 10.2147/CE.S93717. eCollection 2016.
Zotero 插件